Less than a week after hinting at an international perpetual preferred listing, Strategy unveils its 10% euro-based Stream issue targeting institutional investors.Markets, MicroStrategy, Bitcoin, NewsRead More

You might also be interested in reading Ashvattha Therapeutics Presents Positive Interim Phase 2 Results for Subcutaneous Migaldendranib Treatment for DME and Wet-AMD at 2025 MaculArt Meeting.